Browsing HVH - Articles científics by Author "Kapur, Gaurav"
Now showing items 1-1 of 1
-
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
Ariceta Iraola, Gema; Dixon, Bradley; Kim, Seong Heon; Kapur, Gaurav; Mauch, Teri; Ortiz, Stephan (Elsevier, 2021-07)